Hologic, Inc.
HOLX
|
$75.265
0.22%
470K
|
Health Technology
(0.0% 1d) (-0.2% 1m) (-10.9% 1y) (0.0% 2d) (0.0% 3d) (-3.4% 7d) (-3.78% volume)
Earnings Calendar: 2024-02-01
Market Cap: $ 17,667,067,928
http://www.hologic.com
Sec Filling | Patents | 5814 employees
Hologic, Inc. engages in the development, manufacture and supply of diagnostics products, medical imaging systems and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Breast Health segment includes a portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and invasive breast biopsy devices, breast biopsy site markers and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, protection assay and dual kinetic assat technologies, instrumentation and Invader Chemistry Platform. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.
computational women diagnostics osteoporosis bone
add to watch list Paper trade email alert is off
Press-releases
STD Testing Market Projected to Reach $14.11 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-13 (Crawled : 04:20) - prnewswire.com
HOLX | $75.265 0.22% 470K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $544.01 0.46% 470K
|
Health Technology
| Email alert
Add to watchlist
report reach market
Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
Published: 2024-04-11 (Crawled : 19:00) - biospace.com/
HOLX | $75.265 0.22% 470K
|
Health Technology
|
| O: 0.73%
H: 0.09%
C: -0.51%
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
HOLX | $75.265 0.22% 470K
|
Health Technology
|
| O: 0.0%
H: 0.12%
C: -0.05%
financial results
DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates
Published: 2024-03-30 (Crawled : 04:20) - prnewswire.com
ABCM | $23.99 0.0% 7.4M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $60.79 -4.24% 1.1M
|
Health Technology
| Email alert
Add to watchlist
HOLX | $75.265 0.22% 470K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.07 0.33% 740K
|
Health Technology
| Email alert
Add to watchlist
PACB | $1.56 6.85% 12M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.03 1.42% 500K
|
Health Technology
| Email alert
Add to watchlist
A | $132.86 0.32% 620K
|
Health Technology
| Email alert
Add to watchlist
BIO | News | $277.33 -1.31% 110K
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.015 1.38% 290K
|
Health Technology
| Email alert
Add to watchlist
ABCZF | $22.1 -2.32% 4K
|
Health Technology
| Email alert
Add to watchlist
dna technology
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Published: 2024-03-29 (Crawled : 12:30) - prnewswire.com
HOLX | $75.265 0.22% 470K
|
Health Technology
| Email alert
Add to watchlist
lung cancer acquisition medical diagnostics foundation platform
In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets™
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
QGEN | $40.015 1.38% 290K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
DHR | $235.0 -0.58% 1.1M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -0.43%
BIO | News | $277.33 -1.31% 110K
|
Health Technology
|
| O: 0.62%
H: 2.18%
C: 2.02%
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.34%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 0.86%
H: 1.26%
C: 1.18%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SRDX | $26.345 -0.17% 15K
|
Health Technology
|
| O: 0.99%
H: 2.11%
C: 1.09%
QGEN | $40.03 1.42% 500K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
HOLX | $75.265 0.22% 470K
|
Health Technology
|
| O: 0.56%
H: 1.01%
C: 0.98%
AXDX | $0.819 6.36% 30K
|
Health Technology
|
| O: 4.13%
H: 1.0%
C: 1.0%
diagnostics market
Europe Cancer Diagnostics Market Sees Promising Growth Amid Rising Demand for Precision Diagnostics - Forecasts to 2031
Published: 2024-03-01 (Crawled : 00:20) - prnewswire.com
HOLX | $75.265 0.22% 470K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.07 0.33% 740K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.03 1.42% 500K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.015 1.38% 290K
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $544.01 0.46% 470K
|
Health Technology
| Email alert
Add to watchlist
CAJFF | News | $29.0664 760
|
Electronic Technology
| Email alert
Add to watchlist
CAJPY | News | $28.42 29K
|
n/a
| Email alert
Add to watchlist
europe precision cancer diagnostics growth market
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
Published: 2024-02-06 (Crawled : 13:30) - globenewswire.com
FEMY | News | $1.305 -0.38% 120K
|
Manufacturing
|
| O: -0.01%
H: 14.27%
C: 13.29%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
PODD | $164.07 -0.4% 310K
|
Health Technology
|
| O: 0.74%
H: 2.74%
C: 2.38%
HOLX | $75.265 0.22% 470K
|
Health Technology
|
| O: 0.6%
H: 2.9%
C: 2.35%
commercial
FDA Roundup: February 2, 2024
Published: 2024-02-02 (Crawled : 20:00) - prnewswire.com
HOLX | $75.265 0.22% 470K
|
Health Technology
| Email alert
Add to watchlist
fda
Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
Published: 2024-02-01 (Crawled : 00:00) - biospace.com/
HOLX | $75.265 0.22% 470K
|
Health Technology
|
| O: 0.01%
H: 0.33%
C: -0.05%
first system diagnostics
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Last 48 Hours Insiders Buying
CLSD | $1.42 7.58% 130K
|
Health Technology
|
14:00
CDZI P 25000 | $2.25 100K
|
Utilities
|
14:00
ETST P 39000 | $0.068 43K
|
Manufacturing
|
13:30
FNLC P 1275 | $22.62 2.08% 8K
|
Finance
|
12:30
ADMQ | $0.0532 480K
|
|
10:30
AXR P 2400 | $21.02 -5.19% 3.5K
|
Finance
|
21:00
QCRH P 118 | $56.48 1.93% 15K
|
Finance
|
18:01
VUZI P 7500 | $1.26 230K
|
Electronic Technology
|
18:00
RMCF | $3.57 0.56% 7.9K
|
Consumer Non-Durables
|
20:10